Related Experiment Video
Updated: Nov 8, 2025
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.8K
An analysis of hospital pharmacy practice in Namibia, based on FIP's Basel Statements
Andrea Bare1, Marianne Ivey2, Dan Kibuule3
1ThinkWell, Lutherville, MD, USA.
The International Journal of Pharmacy Practice
|April 23, 2021
Summary
Hospital pharmacists in Namibia are eager to enhance patient care and public health outcomes. Leveraging the strong pharmacy education system and therapeutics committees can advance hospital pharmacy practice and improve medicine use.
Area of Science:
- Pharmaceutical Sciences
- Public Health
- Health Services Research
Background:
- Sub-Saharan Africa faces a dual burden of infectious and non-communicable diseases.
- Strengthening hospital pharmacy practice is crucial for improving patient safety and treatment outcomes in the region.
Purpose of the Study:
- To evaluate the current status of hospital pharmacy practice in Namibia.
- To identify opportunities for pharmacists to address public health issues and optimize medication use.
Main Methods:
- A survey using the International Pharmaceutical Federation (FIP) self-assessment tool was conducted.
- Hospital pharmacists across Namibia participated in the study.
- Data analysis involved descriptive statistics and thematic analysis of quantitative and qualitative data.
Main Results:
- The study included 24 hospital pharmacies, primarily public (67%).
- Current activities focus on medicine procurement, preparation, and distribution.
- Key barriers include limited human resources, interprofessional collaboration challenges, and policy gaps.
Conclusions:
- Hospital pharmacists show a strong commitment to improving patient outcomes and public health.
- Namibia's robust pharmacy education system is a valuable asset for advancing practice.
- Therapeutics committees offer a platform for policy change and optimizing pharmacist contributions.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
522
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
522
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
43
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
43
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
54
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
54
01:19Pharmacovigilance
1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
01:28International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
01:22Healthcare Associated Infections II: Preventive Measures
3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K